Hathirat P, Chuansumrit A, Nitiyanant P, Kraipibool P, Ruangdaraganon N, Mahaphan W, Daengprasert S, Isarangkura P
Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
J Med Assoc Thai. 1993 Oct;76 Suppl 2:72-9.
Retrospective analysis of childhood histiocytoses treated at the Department of Pediatrics, Ramathibodi Hospital from May 1970 till June 30, 1992 to verify the prevalence according to the recent classification, course and prognosis was conducted. Among 120 cases, 54 were Class I or Langerhan Cell Histiocytosis (LCH, previously called Histiocytosis-X). Nineteen cases were Class II: Infection-Associated Hemophagocytic Syndrome (IAHS) and Sinus Histiocytosis. Forty-seven cases were class III which included acute monocytic leukemia, juvenile CML; malignant histiocytosis, HMR, and histiocytic lymphoma. Excellent prognosis (cure) was seen in all cases of Hand-Schuller Christian Disease, eosinophilic granuloma, sinus histiocytosis with massive lymphadenopathy and many cases of Class II (except IAHS). The worse prognosis (100% mortality rate) was seen in HMR and juvenile CML. The intermediate prognosis (50%, 54%, 58.8% and 66.7% mortality rate) was seen in MH, HL, LSD and IAHS respectively. To differentiate between IAHS and MH/HMR, the prominent bone marrow findings in 12 cases of IAHS revealed that every case showed prominent hemophagocytosis by the promono-histiocytes/histiocytes, the maximal total erythroblasts (TE) were only 7.5 per cent except for 3 cases; in which one case with agranulocytosis from co-trimoxazole had 84 per cent erythroid cells, one case with prior co-trimoxazole treatment had 37 per cent TE, the last one had 40 per cent TE with massive GI bleeding while in the recovery stage of DHF. All 5 cases of HMR had prominent hemophagocytosis and increased TE (> 22%).(ABSTRACT TRUNCATED AT 250 WORDS)
对1970年5月至1992年6月30日在拉玛提波迪医院儿科治疗的儿童组织细胞增多症进行回顾性分析,以根据最新分类、病程和预后核实其患病率。在120例病例中,54例为I类或朗格汉斯细胞组织细胞增多症(LCH,以前称为组织细胞增多症-X)。19例为II类:感染相关噬血细胞综合征(IAHS)和窦性组织细胞增多症。47例为III类,包括急性单核细胞白血病、青少年慢性粒细胞白血病;恶性组织细胞增多症、HMR和组织细胞淋巴瘤。在所有汉-许-克病、嗜酸性肉芽肿、伴有巨大淋巴结病的窦性组织细胞增多症病例以及许多II类病例(IAHS除外)中,预后良好(治愈)。HMR和青少年慢性粒细胞白血病的预后较差(死亡率100%)。中间预后(死亡率分别为50%、54%、58.8%和66.7%)分别见于恶性组织细胞增多症、组织细胞淋巴瘤、勒-雪病和IAHS。为区分IAHS与恶性组织细胞增多症/HMR,12例IAHS的显著骨髓检查结果显示,每例均显示原单核-组织细胞/组织细胞显著噬血细胞现象,除3例病例外,最大总幼红细胞(TE)仅为7.5%;其中1例因复方新诺明导致粒细胞缺乏症的病例有84%的红细胞,另1例曾接受复方新诺明治疗的病例有37%的TE,最后1例在登革出血热恢复期伴有大量胃肠道出血时TE为40%。所有5例HMR均有显著噬血细胞现象且TE增加(>22%)。(摘要截取自250字)